2008 |
August 13, 2008 GPC Biotech Reports Financial Results for Second Quarter and First Six Months of 2008 |
8. August 2008 GPC Biotech Schedules Conference Call on August 13th to Discuss First Half 2008 Financial Results |
6. August 2008 GPC Biotech Reports that Celgene to Terminate Co-Development and License Agreement for Satraplatin |
July 25, 2008 GPC Biotech Reports that Marketing Authorization Application for Satraplatin is to be Withdrawn |
July 17, 2008 GPC Biotech To Re-Schedule Annual Shareholders’ Meeting |
June 24, 2008 GPC Biotech Announces Initiation of NCI-Sponsored Phase 2 Trial of Satraplatin in Patients with Metastatic Hormone-Refractory Prostate Cancer Previously Treated with Docetaxel |
June 12, 2008 GPC Biotech Announces Granting of European Patent Related to Satraplatin for Treating Tumors Resistant or Refractory to Taxanes |
June 5, 2008 GPC Biotech to Present at Two Upcoming Conferences: 7th Annual Needham Biotechnology & Medical Technology Conference in New York and Piper Jaffray Europe Conference in London |
June 2, 2008 Data from Satraplatin SPARC Phase 3 Trial in Patients with Hormone-Refractory Prostate Cancer Progressing after Initial Chemotherapy Presented at 44th ASCO Annual Meeting |
June 2, 2008 New Data from Several Satraplatin Clinical Trials in Solid Tumors Presented at 44th ASCO Annual Meeting |
May 28, 2008 GPC Biotech Announces Data from Several Satraplatin Clinical Trials to be Presented at ASCO Annual Meeting |
May 15, 2008 GPC Biotech Reports Financial Results for First Quarter 2008 |
May 9, 2008 GPC Biotech Schedules Conference Call on May 15th to Discuss First Quarter 2008 Financial Results |
March 27, 2008 GPC Biotech Reports Financial Results for Fiscal Year 2007 |
13. März 2008 GPC Biotech to Present at Cowen and Company 28th Annual Health Care Conference in Boston |
March 5, 2008 GPC Biotech to Hold Conference Call on March 27, 2008 to Discuss Year-End 2007 Financial Results |
25. February 2008 GPC Biotech Announces Corporate Restructuringand Provides Pipeline Update |
January 7, 2008 GPC Biotech to Provide Update on Research and Development Programs at JPMorgan 26th Annual Healthcare Conference in San Francisco |
